Elevance Health, Inc. earnings per share and revenue
On Oct 21, 2025, ELV reported earnings of 6.03 USD per share (EPS) for Q3 25, beating the estimate of 4.98 USD, resulting in a 21.02% surprise. Revenue reached 50.09 billion, compared to an expected 49.86 billion, with a 0.45% difference. The market reacted with a -1.22% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 22 analysts forecast an EPS of 3.18 USD, with revenue projected to reach 50.31 billion USD, implying an decrease of -47.26% EPS, and increase of 0.45% in Revenue from the last quarter.
FAQ
What were Elevance Health, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Elevance Health, Inc. reported EPS of $6.03, beating estimates by 21.02%, and revenue of $50.09B, 0.45% above expectations.
How did the market react to Elevance Health, Inc.'s Q3 2025 earnings?
The stock price moved down -1.22%, changed from $354.07 before the earnings release to $349.75 the day after.
When is Elevance Health, Inc. expected to report next?
The next earning report is scheduled for Jan 28, 2026.
What are the forecasts for Elevance Health, Inc.'s next earnings report?
Based on 22
analysts, Elevance Health, Inc. is expected to report EPS of $3.18 and revenue of $50.31B for Q4 2025.